Article Text

Download PDFPDF
Decision-making in patients with advanced cancer compared with amyotrophic lateral sclerosis
  1. A B Astrow1,2,3,
  2. J R Sood2,3,
  3. M T Nolan4,
  4. P B Terry4,
  5. L Clawson4,
  6. J Kub4,
  7. M Hughes4,
  8. D P Sulmasy2,3
  1. 1
    Maimonides Medical Center, Brooklyn, New York, USA
  2. 2
    St Vincent’s Hospital Manhattan, New York, New York, USA
  3. 3
    New York Medical College, Valhalla, New York, USA
  4. 4
    The Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
  1. Dr D P Sulmasy, Saint Vincent Catholic Medical Centers Manhattan, Department of Ethics, 153 West 11th Street, NR 817, New York, NY 10011, USA; daniel_sulmasy{at}


Aim: Patients with advanced cancer need information about end-of-life treatment options in order to make informed decisions. Clinicians vary in the frequency with which they initiate these discussions.

Patients and methods: As part of a long-term longitudinal study, patients with an expected 2-year survival of less than 50% who had advanced gastrointestinal or lung cancer or amyotrophic lateral sclerosis (ALS) were interviewed. Each patient’s medical record was reviewed at enrollment and at 3 months for evidence of the discussion of patient wishes concerning ventilator support, artificial nutrition and hydration (ANH), resuscitation (DNR) and hospice care. A Kaplan–Meier analysis was also performed and 2-year survival calculated.

Results: 60 cancer and 32 ALS patients were enrolled. ALS patients were more likely than cancer patients to have evidence of discussion about their wishes for ventilator support (31% vs 0%, p<0.001), ANH (38% vs 0%, p<0.001), DNR (25% vs 0%, p<0.001) and hospice care (22% vs 5%, p = 0.03). At 6 months, 91% of ALS patients were alive compared with 62% of cancer patients; at 2 years, 63% of ALS patients were alive compared with 23% of cancer patients (p<0.001).

Conclusions: Cancer patients were less likely than ALS patients to have had documented advanced care planning discussions despite worse survival. This may reflect perceptions that ALS has a more predictable course, that advanced cancer has a greater number of treatment options, or differing views about hope. Nevertheless, cancer patients may be less adequately prepared for end-of-life decision-making.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Competing interests: None.

  • Funding: This study was funded by the National Institute of Nursing Research at the National Institutes of Health (1 R01 NR005224-01A1), by a grant from the Leslie R Samuels and Fan Fox Foundation (administered by the Partnership for Caring) and by the ALS Research Center of the Johns Hopkins University

  • Ethics approval: The study was approved by the institutional review boards at the Johns Hopkins Medical Institutions in Baltimore, Maryland and St Vincent’s Hospital Manhattan.

Other content recommended for you